karma stocks - The stock market world
« Precedenti Successivi »
 

iMing Corp. Plans to Open a E-Commerce Online Reta

HONG KONG, CHINA--(CRWENewswire - Dec. 10, 2012) - iMing Corp. (OTC PINK:IMNG) announced today that the company plans to open a E-commerce online retail store at Taobao Marketplace. Taobao Marketplace is a Chinese language web site for online shopping, similar to eBay and Amazon, operated in China. Founded by Alibaba Group in May 10, 2003,…
 

Data From Non HSCT VOD Patients Treated With Defib

VILLA GUARDIA (COMO), Italy, Dec. 7, 2012 (CRWENewswire) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced that an oral presentation and poster abstracts on Defibrotide will be presented at the 54th Annual Meeting and Exposition of the American Society of Hematology to be held at the Georgia World Congress Center in Atlanta, Georgia, December 8-11,…
 

Lockheed Martin's PAC-3 MSE Missile Successfully I

DALLAS, Dec. 6, 2012 (CRWENewswire) -- Lockheed Martin's (NYSE:LMT) PAC-3 Missile Segment Enhancement (MSE) successfully engaged, intercepted and destroyed a tactical ballistic missile (TBM) target today at White Sands Missile Range, N.M. The first interceptor destroyed the target and the second PAC-3 MSE Missile self-destructed as planned."Today's flight test provided another example of how the…
 

Achmea (Australia) Selected Sapiens IDIT Software

Following Achmea's selection of Sapiens IDIT as its strategic global solution across all operating companies in the groupREHOVOT, Israel, December 5, 2012 (CRWENewswire) --Sapiens International Corporation N.V. (NASDAQ and TASE: SPNS), a provider of innovative insurance software solutions and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), announces today that Achmea Insurance…
 

Galena Biopharma Announces Signature of Commercial

* Partnership includes future commercialization of NeuVax(TM) in Israel and financial support* Key clinical sites approved and established in Israel for PRESENT Phase 3 trialLAKE OSWEGO, Ore., Dec. 4, 2012 (CRWENewswire) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments, today announced it has signed an agreement with a…
 

PEEK Extends Tender Offer for Shares of LookSmart

NEW YORK, Dec. 2, 2012 (CRWENewswire) -- PEEK Investments LLC today issued the following statement:"We have extended our third-party tender offer to purchase all of the outstanding shares of common stock of LookSmart, Ltd. (Nasdaq:LOOK) for $1.00 per share in cash. As extended, the tender offer is scheduled to expire at 5:00 P.M., New York…
 

Whole Foods Market Announces Special Cash Dividend

AUSTIN, Texas, Nov. 29, 2012 (CRWENewswire) -- Whole Foods Market, Inc. (Nasdaq:WFM) announced that its Board of Directors has declared a special cash dividend on Whole Foods Market common stock of $2.00 per share payable December 21, 2012, to shareholders of record on the close of business on December 10, 2012. The aggregate amount of…
 

Grace Completes the Acquisition of Assets of Noble

QINGDAO, China--(CRWENewswire)--W. R. Grace & Co. (NYSE:GRA) announced today that it has completed its acquisition of the assets of Noblestar Catalysts Co., Ltd, a Qingdao, China-based manufacturer of fluid catalytic cracking (FCC) catalysts, catalyst intermediates and related products used in the petroleum refining industry. Grace is the worldwide leader in FCC catalysts.Qingdao Bureau of Commerce…
 

Cadence Pharmaceuticals Announces Settlement of OF

SAN DIEGO, Nov. 28, 2012 (CRWENewswire) -- Cadence Pharmaceuticals, Inc. (Nasdaq:CADX) today announced that it has entered into settlement and license agreements with Perrigo Company (Nasdaq:PRGO; TASE), and its subsidiary, Paddock Laboratories, LLC, to resolve pending patent litigation involving OFIRMEV® (acetaminophen) injection.The settlement agreement includes a stipulation by the parties requesting dismissal with prejudice of…
 

Amarantus BioSciences Announces Positive Data for

SUNNYVALE, Calif., Nov. 27, 2012 (CRWENewswire) -- Amarantus BioSciences, Inc. (OTCQB:AMBS), a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has successfully completed experiments demonstrating that MANF has an excellent diffusion profile in the striatum…
 

« Precedenti Successivi »